| Quercetin inhibits prostate cancer by attenuating cell survival and inhibiting anti-apoptotic pathways. SS Ashley B Ward, Hina Mir, Neeraj Kapur, Dominique N Gales, Patrick P Carriere World J Surg Oncol 16 (1), 108, 2018 | 159* | 2018 |
| Hepatitis E virus enters liver cells through receptor‐dependent clathrin‐mediated endocytosis N Kapur, D Thakral, H Durgapal, SK Panda Journal of viral hepatitis 19 (6), 436-448, 2012 | 77 | 2012 |
| Subcellular localization of hepatitis E virus (HEV) replicase S Rehman, N Kapur, H Durgapal, SK Panda Virology 370 (1), 77-92, 2008 | 77 | 2008 |
| Hepatitis E virus (HEV) protease: a chymotrypsin-like enzyme that processes both non-structural (pORF1) and capsid (pORF2) protein D Paliwal, SK Panda, N Kapur, SPK Varma, H Durgapal Journal of General Virology 95 (8), 1689-1700, 2014 | 65 | 2014 |
| CC chemokines are differentially expressed in Breast Cancer and are associated with disparity in overall survival. SS Thomas JK, Mir H, Kapur N, Bae S Sci Rep 9 (1:4014), 2019 | 59 | 2019 |
| CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering R Singh, N Kapur, H Mir, N Singh, JW Lillard Jr, S Singh Oncotarget 7 (6), 7343, 2016 | 59 | 2016 |
| Emodin inhibits colon cancer by altering BCL-2 family proteins and cell survival pathways. SS Saunders IT, Mir H, Kapur N Cancer Cell Int. 19 (98), 2019 | 52 | 2019 |
| Andrographolide inhibits prostate cancer by targeting cell cycle regulators, CXCR3 and CXCR7 chemokine receptors H Mir, N Kapur, R Singh, G Sonpavde, JW Lillard Jr, S Singh Cell Cycle 15 (6), 819-826, 2016 | 47 | 2016 |
| CCR6 expression in colon cancer is associated with advanced disease and supports epithelial-to-mesenchymal transition N Kapur, H Mir, CE Clark III, U Krishnamurti, DJ Beech, JW Lillard, ... British journal of cancer 114 (12), 1343-1351, 2016 | 43 | 2016 |
| Hepatitis E virus replication involves alternating negative-and positive-sense RNA synthesis SPK Varma, A Kumar, N Kapur, H Durgapal, SK Acharya, SK Panda Journal of general virology 92 (3), 572-581, 2011 | 38 | 2011 |
| Racial differences in immunological landscape modifiers contributing to disparity in prostate cancer J King Thomas, H Mir, N Kapur, S Singh Cancers 11 (12), 1857, 2019 | 31 | 2019 |
| Higher CXCL16 exodomain is associated with aggressive ovarian cancer and promotes the disease by CXCR6 activation and MMP modulation. SS Mir H, Kaur G, Kapur N, Bae S, Lillard JW Jr Sci Rep 9 (1:2527.), 2019 | 31 | 2019 |
| Prostate cancer cells hyper-activate CXCR6 signaling by cleaving CXCL16 to overcome effect of docetaxel. SS N Kapur, H Mir , GP Sonpavde, S Jain, S Bae, JW Lillard Jr Cancer Lett. 454, 1-13, 2019 | 22 | 2019 |
| Recombinant Hepatitis E virus like particles can function as RNA nanocarriers SK Panda, N Kapur, D Paliwal, H Durgapal Journal of nanobiotechnology 13, 1-6, 2015 | 14 | 2015 |
| Cinnamtannin B-1 inhibits cell survival molecules and induces apoptosis in colon cancer. SS Carriere PP, Kapur N, Mir H, Ward AB Int J Oncol. 53 (4), 1442-1454, 2018 | 13 | 2018 |
| CXCR6-CXCL16 axis promotes breast cancer by inducing oncogenic signaling H Mir, N Kapur, DN Gales, PK Sharma, G Oprea-Ilies, AT Johnson, ... Cancers 13 (14), 3568, 2021 | 9 | 2021 |
| DPP-4 as a novel biomarker for inflammatory bowel disease: Is it ready for clinical use? C Perry, N Kapur, TA Barrett Inflammatory Bowel Diseases 26 (11), 1720-1721, 2020 | 6 | 2020 |
| AUPHOS, a “first-in class” oral agent for correcting metabolic dysfunction in IBD L Wempe, R Mohamed, J Warinner, T Goretsky, M Avdiushko, J Kim, ... Gastroenterology 162 (3), S2, 2022 | 5 | 2022 |
| CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and alphavbeta3 integrin clustering. Oncotarget 7, 7343–7353 R Singh, N Kapur, H Mir, N Singh, JW Lillard Jr, S Singh | 5 | 2016 |
| Emodin inhibits colon cancer by modulating apoptotic and cell survival signals IT Saunders, N Kapur, H Mir, S Singh Cancer Research 78 (13_Supplement), 312-312, 2018 | 4 | 2018 |
